UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 88

Sortiert nach

Cumulative tenofovir diphosphate exposure in persons with HIV taking single‐ vs. multiple‐tablet regimens

Pharmacotherapy, 2022-08, Vol.42 (8), p.641-650

2022

Link zum Volltext

Verfügbarkeit prüfen

Higher medication complexity in persons with HIV is associated with lower tenofovir diphosphate in dried blood spots

Pharmacotherapy, 2021-03, Vol.41 (3), p.291-298

2021

Link zum Volltext

Verfügbarkeit prüfen

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy

Antimicrobial agents and chemotherapy, 2018-01, Vol.62 (1)

2018

Link zum Volltext

Verfügbarkeit prüfen

Long‐acting injectable Cabotegravir: How drug concentrations could help guide patient management

British journal of clinical pharmacology, 2022-10, Vol.88 (10), p.4384-4386

2022

Link zum Volltext

Verfügbarkeit prüfen

Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study

Journal of the International AIDS Society, 2019-06, Vol.22 (6), p.e25297-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir diphosphate levels in dried blood spots are associated with virologic failure and resistance to first‐line therapy in South Africa: a case–control cohort study

Journal of the International AIDS Society, 2021-12, Vol.24 (12), p.e25849-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure

AIDS research and human retroviruses, 2013-02, Vol.29 (2), p.384

2013

Link zum Volltext

Verfügbarkeit prüfen

Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State

AIDS research and human retroviruses, 2016-11, Vol.32 (10-11), p.981

2016

Link zum Volltext

Verfügbarkeit prüfen

Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring

Current HIV/AIDS reports, 2018-02, Vol.15 (1), p.49-59

2018

Link zum Volltext

Verfügbarkeit prüfen

Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates

PloS one, 2016-11, Vol.11 (11), p.e0165505

2016

Link zum Volltext

Verfügbarkeit prüfen

Beyond HIV viral load: application of pharmacologic measures to identify ART adherence mismatch

Therapeutic advances in infectious disease, 2021, Vol.8, p.204993612110105

2021

Link zum Volltext

Verfügbarkeit prüfen

Adherence to Antiretroviral Therapy and Pre-exposure Prophylaxis: TARGETing the Ideal Measure

Clinical infectious diseases, 2020-05, Vol.70 (10), p.2152-2154

Castillo-Mancilla, Jose R

2020

Link zum Volltext

Verfügbarkeit prüfen

Advances in Long-Acting Agents for the Treatment of HIV Infection

Drugs (New York, N.Y.), 2020-04, Vol.80 (6), p.535-545

2020

Link zum Volltext

Verfügbarkeit prüfen

The use of technology-based adherence monitoring in the treatment of hepatitis C virus

Therapeutic Advances in Infectious Disease, 2022, Vol.9, p.204993612210956

2022

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus Infections

Clinical infectious diseases, 2019-04, Vol.68 (8), p.1335-1342

2019

Link zum Volltext

Verfügbarkeit prüfen

Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIV

The Journal of infectious diseases, 2019-07, Vol.220 (4), p.635-642

2019

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of a Career Development Award (Pre-K) Mock Review Program for Postdoctoral Fellows and Early-Career Faculty

Academic medicine, 2023-11, Vol.98 (11), p.1313

2023

Link zum Volltext

Verfügbarkeit prüfen

Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression

Clinical infectious diseases, 2016-12, Vol.63 (12), p.1661-1667

2016

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in South Africa

AIDS (London), 2022-06, Vol.36 (7), p.933-940

2022

Link zum Volltext

Verfügbarkeit prüfen

Individualized Adherence Benchmarks for HIV Pre-Exposure Prophylaxis

AIDS research and human retroviruses, 2021-06, Vol.37 (6), p.421

2021

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium and high adherence to emtricitabine/ tenofovir alafenamide vs. emtricitabine/ tenofovir disoproxil fumarate

AIDS (London), 2021-12, Vol.35 (15), p.2481-2487

2021

Link zum Volltext

Verfügbarkeit prüfen

Emtricitabine triphosphate in dried blood spots predicts future viremia in persons with HIV and identifies mismatch with self-reported adherence

AIDS (London), 2021-10, Vol.35 (12), p.1949-1956

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparing Predictive Ability of Two Objective Adherence Measures in a Community-Based Cohort on Antiretroviral Therapy in South Africa: Tenofovir Diphosphate Concentrations and Electronic Adherence Monitors

Journal of acquired immune deficiency syndromes (1999), 2023-08, Vol.93 (4), p.327

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(87)
Berichte
(1)

Sprache

Englisch
(88)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cumulative tenofovir diphosphate exposure in persons with HIV taking single‐ vs. multiple‐tablet regimens

Higher medication complexity in persons with HIV is associated with lower tenofovir diphosphate in dried blood spots

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy

Long‐acting injectable Cabotegravir: How drug concentrations could help guide patient management

Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study

Tenofovir diphosphate levels in dried blood spots are associated with virologic failure and resistance to first‐line therapy in South Africa: a case–control cohort study

Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure

Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State

Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring

Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates

Beyond HIV viral load: application of pharmacologic measures to identify ART adherence mismatch

Adherence to Antiretroviral Therapy and Pre-exposure Prophylaxis: TARGETing the Ideal Measure

Advances in Long-Acting Agents for the Treatment of HIV Infection

The use of technology-based adherence monitoring in the treatment of hepatitis C virus

Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus Infections

Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIV

Outcomes of a Career Development Award (Pre-K) Mock Review Program for Postdoctoral Fellows and Early-Career Faculty

Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression

Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in South Africa

Individualized Adherence Benchmarks for HIV Pre-Exposure Prophylaxis

Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium and high adherence to emtricitabine/ tenofovir alafenamide vs. emtricitabine/ tenofovir disoproxil fumarate

Emtricitabine triphosphate in dried blood spots predicts future viremia in persons with HIV and identifies mismatch with self-reported adherence

Comparing Predictive Ability of Two Objective Adherence Measures in a Community-Based Cohort on Antiretroviral Therapy in South Africa: Tenofovir Diphosphate Concentrations and Electronic Adherence Monitors

Viral and host mediators of non-suppressible HIV-1 viremia

Tenofovir-Diphosphate and Emtricitabine-Triphosphate Adherence Benchmarks in Dried Blood Spots for Persons With Human Immunodeficiency Virus Receiving Tenofovir Alafenamide and Emtricitabine–Based Antiretroviral Therapy (QUANTI-TAF)

Suchergebnisse filtern